Objective. To describe the pseudotumoural presentation of neuro-Behç et's disease (NBD).
Introduction
Behç et's disease (BD) is a rare systemic vasculitis of unknown aetiology first described in 1937, with predominance of mucocutaneous and ocular lesions. Diagnosis criteria from the International Study Group for Behç et's Disease [1] included major manifestations (recurrent oral ulceration) and minor signs (genital ulceration, skin lesions such as erythema nodosum, folliculitis and ulceration, eye involvement such as anterior and/or posterior uveitis and skin pathergy reaction). BD may also involve joints, vascular system, CNS, heart and gastrointestinal tract.
Neurological manifestations are observed in 5.359.0% of cases in BD. Few large series describing the clinical pattern of CNS involvement [26] have been published in BD. CNS involvement included parenchymal and non-parenchymal (i.e. cerebral venous thrombosis or arterial aneurysm) lesions. Parenchymal lesions may occur in 81% [2] of neuro-BD (NBD), and frequently onset with an attack rather than a mild progressive course. Clinical features frequently consist of headache, pyramidal signs with hemiparesis, behavioural change and sphincter impotence, whereas morphological findings show inflammatory lesions in the brainstem and hemispheric area. Typical MRI findings are small scattered lesions in multiple areas of the basal ganglion region, brainstem or internal capsule, with hypersignal in T2-weighted MRI and contrast enhancement with gadolinium. According to the pathological and necropsical studies, NBD is related to multifocal inflammatory and necrotic lesions and perivascular neutrophilic and lymphocytic infiltrates. Treatment with steroid and immunosuppressive agents may induce rapid clinical and morphological improvement.
Besides this typical neurological presentation, few case reports of pseudotumoural NBD have yet been reported. The pseudotumoural form of NBD is a rare, lifethreatening condition that may lead to severe disability and death. It may precede the mucocutaneous manifestations of BD and induce delayed diagnosis. The pseudotumoural form of NBD deserves to be known, as a rapid recognition of this condition may avoid inadequate surgical procedures, sequelae and/or death.
Herein we report the first case series of the pseudotumoural form of NBD, including 5 personal observations and a review of 18 cases from the literature. We analysed the main clinical and imaging neurological features, treatment and outcome. We then compared the main characteristics and outcome of the 23 pseudotumoural cases of NBD to a personal series of 69 patients with a classical form of NBD.
Patients and methods

Pseudotumoural NBD
We systematically reviewed the medical files of 275 (33.5% of our cohort of 820 BD patients) patients with NBD seen between 1974 and 2010 in the Department of Internal Medicine of Pitié -Salpé triè re Hospital, Paris, France (Fig. 1 ). Among the 275 NBD patients, 68 (24.7%) patients with non-parenchymal CNS involvement [i.e. cerebral venous thrombosis (n = 64) [7] and cerebral aneurysm (n = 4)] were excluded. Two hundred and two (73.5%) patients had a classical parenchymal NBD, and we found five patients (1.8%) with a pseudotumoural form of NBD. All patients were classified as BD according to O'Duffy criteria and/or expert opinion [8] . Patients with pseudotumoural NBD were defined by the presence of severe neurological symptoms associated with at least one large space-occupying lesion on MRI and/or CT scan imaging. All parenchymal NBD patients were classified as BD according to O'Duffy criteria and expert opinion [8] . One of our five personal cases of the pseudotumoural form of NBD was previously reported [9] . Data regarding age, gender, date of BD criteria and of NBD diagnosis, clinical manifestations of BD (mucocutaneous lesions, eyes, joint and vascular involvement), neurological symptoms, CNS imaging, CNS pathology (when available), treatment and outcome were collected. To describe the neurological presentation, the following terms were used, as previously reported [2] : (i) attack was defined as acute or subacute (<15 days) onset of the neurological symptoms; (ii) primary progressive course was determined slowly evolving symptoms with no preceding attack; and (iii) secondary progressive course was defined as slowly evolving neurological manifestations after at least one attack, or step-wise progression. To describe initial status and outcome under treatment, the Rankin's score was used as a marker of disability status and graded as follows: 0: no symptoms at all; 1: no significant disability despite symptoms; able to carry out all usual duties and activities; 2: slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance;
3: moderate disability; requiring some help, but able to walk without assistance;
4: moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance; 5: severe disability; bedridden, incontinent and requiring constant nursing care and attention; and 6: dead.
Complete response under treatment was defined as a complete clinical and imaging remission, and the absence of sequelae. Partial response was defined as an incomplete clinical and imaging improvement.
We then screened the medical literature using PubMed (http://www.ncbi.nlm.nih.gov/pubmed) by entering the following keywords: Behç et's disease, neuro-Behç et's, neurological, pseudotumoural, with no limit of publication date. Nineteen cases of pseudotumoural neuro-Behç et's presentation were found since 1987 to date and were reviewed in the present study. One of the 19 cases was excluded, because the pseudotumoural presentation was related to a cerebral venous thrombosis, without proper parenchymal involvement of the CNS [10] . The 18 remaining cases were added to our 5 patients in order to provide a global description of the pseudotumoural form of NBD.
FIG. 1
Characteristics of patients included in the study. For this study, 18 cases of pseudotumoural NBD from the literature were added to our 5 personal cases for analysis.
www.rheumatology.oxfordjournals.org Classical NBD Sixty-nine selected patients of our 202 classical parenchymal NBD patients with complete extractable outcome data at the time of study were included and compared with patients with the pseudotumoural form of NBD. Demographical characteristics, clinical manifestations, neurological presentation, treatment and outcome were compared between the two groups.
Statistical analysis
Results are presented as the median (25th75th interquartile range) or n (%). MannWhitney U-test and Fisher's exact test were used to compare non-parametric continuous and categorical variables between groups, respectively. P < 0.05 was considered statistically significant. Data were stored in the GraphPad PRISM 5.01 package.
Results
We reported 23 cases of pseudotumoural NBD (5 diagnosed in our department between 1993 and 2010 and a review of 18 cases from the literature published since 1987).
Personal cases
Case 1 [9] was a 57-year-old Caucasian woman with BD diagnosed in 1984 (oral and genital ulceration, uveitis). She presented in 1995 with intracranial hypertension, severe headache and ataxia. CT scan showed a large hypodensity in the right thalamus without contrast enhancement. MRI showed a pseudotumoural lesion in right capsulo-lenticular area with a mass effect. Aseptic meningitis was associated (cellularity 815/mm 3 , lymphocytosis 84%, proteinorrachia 0.65 g/l). Treatment with methylprednisolone (1 g/day for 3 days) was initiated and relayed with oral prednisone (1 mg/kg/day) and i.v. CYC (1 g/month; total of 18 pulses) for 2 years. Clinical and morphological complete response was achieved within 1 month. After a follow-up of 15 years, she remained in good health with no relapse of NBD. Case 2 was a 47-year-old African man with a 3-year history of orogenital ulceration and uveitis. In 1995 he presented tetra-pyramidal signs with right spastic hemiplegia and left hemiparesia. Morphological imaging showed a large mass in the brainstem, extended to the bilateral cerebral peduncles, basal ganglia and bilateral capsulothalamic regions. He had no associated meningitis. After the exclusion of infectious disease, severe pseudotumoural NBD with a primary progressive course was diagnosed. Despite steroids and AZA, his neurological status worsened. Ophthalmoplegia, bulbar symptoms and sphincter disturbance appeared with persistence of the MRI lesions. An i.v. pulse of CYC together with methylprednisolone failed to improve his status, and the immunosuppressive regimen was stopped after 3 years due to lack of efficacy. He died 5 years after the onset of infected leg ulcers related to his bedridden state.
Case 3 was a 48-year-old man with orogenital ulceration for 10 years. He presented behavioural changes and atypical depression for 1 year. He was admitted with fever, headache and tetra-pyramidal signs. MRI showed right capsulo-lenticular T2W hyperintensity with peripheral gadolinium enhancement, associated with small inactive lesions in the brainstem. Aseptic meningitis was associated (cellularity 176/mm 3 , 89% lymphocytes).
He achieved complete clinical and partial morphological response after treatment with i.v. methylprednisolone, oral prednisone and six CYC pulses followed by oral AZA. Case 4 was a 34-year-old man with recurrent oral aphthae and folliculitis. He was hospitalized in July 2009 for right hemipyramidal syndrome and diffuse headache and pulmonary embolism. Morphological examination (CT and MRI) showed a large left capsulo-thalamic lesion with oedema and peripheral contrast enhancement (Fig. 2) . Large antibiotherapy was ineffective and the patient's clinical state worsened. Stereotactic biopsy was performed, and pathological examination showed necrotic lesions with inflammatory infiltration in the white matter. Multifocal lymphocytic, neutrophilic and macrophagic infiltrate with perivascular distribution evoked aseptic presuppurative encephalitis with vasculitis. There was no evidence for infection, solid tumour or lymphoma. Steroid therapy (1 mg/kg/day of oral prednisone) was initiated, with initial clinical improvement, but stopped after 1 month. The same neurological signs reappeared, associated with scrotal ulcers and pseudo-folliculitis and chest pain revealing myocarditis. Steroid therapy led to further improvement, with systematic clinical relapse when tapering. A novel MRI showed progression of cerebral lesions, with apparition of a second one in the right pons with contrast enhancement. The patient was referred to our centre 1 year after the first attack. Physical examination showed severe right hemipyramidal spasticity. A highdose steroid regimen (methylprednisolone, 1 g/day during 3 days relayed with 1 mg/kg/day oral prednisone) and six i.v. CYC pulses (1 g/month) were performed, leading to the stabilization of his clinical state and significant imaging improvement. The patient's Rankin's score remained at 3, with persistent hemiparesis.
Case 5 was a 30-year-old Caucasian man without medical history. He presented in 1990 with headache, behavioural changes and hemiparesis. Morphological examination revealed a T2W hyperintense mass in the brainstem, and cerebrospinal fluid (CSF) analysis showed aseptic meningitis. This first attack spontaneously improved in 3 days, and hence the patient was not treated. He experienced five similar attacks over 2 years, in a secondary progressive course type. Clinical presentation completed with pseudobulbar signs and tetraparesis. Novel MRI showed progressive extension of the mass in a pseudotumoural form in the mid-brain and capsulo-lenticular area. No biopsy was performed and the patient received methylprednisolone during attacks, without DMARDs. Bipolar ulceration then occurred, leading to diagnosis of NBD, and he was referred to our service in 1992. CYC was used (1 g/month) for a few months, but without clinical improvement. Behavioural changes worsened, as well as sphincter impotence. After a 15-year follow-up, the patient was in a bedridden state.
For our five patients, a systematic screening for other pseudotumoural affections was performed. Differential diagnoses such as tuberculosis, syphilis, HIV infection, toxoplasmic infection, lymphoma and/or solid tumour were excluded by appropriate clinical, biological and imaging testing. HLA-B5 typing was positive in all five cases.
Description of pseudotumoural NBD
Clinical description
The clinical characteristics of the 23 patients are summarized in Tables 13. The median age at diagnosis was 39 (2748 years) years, with a male predominance (65.2%). Data concerning extraneurological manifestations of BD were available for 20 patients. They included oral ulceration (n = 19, 95%), genital ulceration (n = 16, 80%), skin manifestations (i.e. folliculitis or erythema nodosum, n = 10, 50%), uveitis (n = 5, 25%), arthritis (n = 3, 15%), orchitis (n = 1, 5%) and myocardial involvement (n = 1, 5%). HLA-B5 typing was positive in 77.7% cases.
Neurological signs were present at the onset of BD in 26.7% of cases (4/15, past medical history non-available for the missing 8 cases). In the whole population, the median time between BD criteria and neurological presentation was 3 years (010 years). Repartition of the clinical course was 15 attacks (65.2%), 1 primary progressive course (4.3%) and 7 secondary progressive courses (30.4%).
Clinical features included hemi-or tetra-pyramidal symptoms (n = 20), headache (n = 17), cerebellar syndrome (n = 3), sphincter impotence (n = 3) and pseudobulbar signs (n = 2). Behavioural changes were common.
Neuroradiology
Cerebral imaging consisted of MRI and/or CT scans. The CNS lesions were distributed in the capsulo-thalamic area www.rheumatology.oxfordjournals.org (n = 16, 69.6%), brainstem (n = 4, 17.4%), cerebellar zone (n = 3, 13%), frontoparietal cortex (n = 2, 8.7%) and temporo-occipital cortex (n = 1, 4.3%). Extensive lesions involving at least two areas were seen in 13 patients, whereas multiple locations (two or more) were seen in 4 patients (refs. [26, 27] and Cases 1 and 5) at onset or during evolution. CT scan revealed large pseudotumoural hypodensity with inconstant peripheral contrast enhancement. MRI showed lesions with T1W spontaneous hypointensity with gadolinium enhancement and T2W hyperintensity. Association with oedema and/or mass effect was evidenced in 20 (87%) cases.
Histopathology
Histological analysis was available in 10 cases (9 from biopsies, 1 from surgical excision), including our Case 4. In the latter, stereotactic biopsy was performed and showed necrotic tissue with perivascular inflammatory infiltrate (T lymphocytes and neutrophils), mimicking aseptic abscess and pre-suppurative encephalitis. The common histological feature was perivascular pleocytic infiltrate (n = 6, 60%). The other descriptions were multifocal necrotic lesions (n = 3, 30%), vasculitis (n = 2, 20%) or reactive gliosis without inflammation (n = 2, 20%).
Treatment and outcome
Information regarding treatment was available for 22/23 patients with pseudotumoural NBD (all except Varoglu et al. [27] ). In 21 (95.5%) patients, a CS regimen was initiated. It was associated with an immunosuppressive agent in 10 cases [CYC (n = 8) and/or AZA (n = 4)]. At diagnosis, 65.2% of pseudotumoural patients had a Rankin's score 53. However, despite the severity of the neurological presentation in the pseudotumoural form, CSs and/or an immunosuppressive regimen improved the prognosis of patients. Complete clinical and morphological response was observed in 14 (60.9%) cases. Seven (30.5%) patients had partial clinical and/or morphological responses. The proportion of patients with significant clinical and morphological improvements 1 month after treatment was 62.5%. A Rankin's score <3 was observed in 34.8% at diagnosis, compared with 78.3% under treatment (P < 0.01).
In two patients (8.7%), the clinical state deteriorated with high-disability status and dependence. In one case [19] , surgical lobectomy was made for decompression of impending herniation because of severe mass effect and oedema, without long-term efficacy. The two patients died because of their bedridden state and infectious complications.
Comparison with classical NBD
We then compared the main characteristics and outcome of the pseudotumoural and classical forms of NBD. The 23 patients with pseudotumoural NBD were compared with 69 unselected, consecutive patients with classical NBD of our cohort. Data are summarized in Table 3 .
No differences were seen in terms of sex ratio, age at presentation or HLA-B5 typing. Patients with the pseudotumoural NBD had longer duration of BD [median duration 3 (010 years) vs 0 (0.33.5 years) years; P = 0.01] and less frequent uveitis (25 vs 59.4%; P = 0.01), joint involvement (15 vs 39.1%; P = 0.06) and venous involvement (5 vs 30.4%; P = 0.02) compared with classical NBD.
Pyramidal signs and hemiparesis were more frequent (87 vs 55.1%; P < 0.01 and 73.9 vs 33.3%; P < 0.01, respectively) in the pseudotumoural NBD than in the classical form (Table 3) . Although not statistically significant, the pseudotumoural NBD tended to have fewer brainstem signs than the classical NBD patients (8.7 vs 26.1%; P = 0.14). As shown in Table 3 , the initial presentation was more severe in the pseudotumoural NBD than in the classical form. At diagnosis, 65.2% of patients with pseudotumoural NBD had a Rankin's score 53, compared with 34.7% of those with classical NBD (P < 0.01).
Morphological examination showed significantly more capsulo-thalamic localization in the pseudotumoural NBD compared with classical NBD (69.6 vs 11.6%; P < 0.01), with large and often unique space-occupying lesions in the pseudotumoural NBD. Classical NBD had more brainstem involvement. No medullar localization was reported in the pseudotumoural form of NBD.
Compared with classical NBD patients, a similar proportion of patients with pseudotumoural NBD were treated with CSs. However, a higher percentage of patients with the classical NBD received DMARDs such as CYC (P = 0.08) and AZA (P = 0.0015) ( Table 3) . Despite a more severe presentation in the pseudotumoural form of NBD, therapy was effective in both groups. Following treatment, 78.3% of patients with the pseudotumoural NBD had a Rankin's score <3, compared with 83% in those with classical NBD (P = 0.75) (Fig. 3) .
Discussion
CNS lesions in BD are polymorph and occur in 5.359.0% of cases [2] . CNS involvement is one of the most severe manifestations of BD [4] . Although extraneurological involvement generally precedes neurological findings, it may be unrecognized in some cases or may appear later in the course of BD, thus inducing diagnostic difficulties. The pseudotumoural form of NBD has been poorly described, and only a few case reports have been reported in the literature. Herein we report the first series of pseudotumoural NBD, providing data on the neurological presentation, treatment and outcome.
As for classical NBD, there was a male predominance [2, 3, 28] . The prevalence of pseudotumoural NBD could be estimated at 1.8% of NBD manifestations in our experience. The HLA-B51 allele was present in 77.8% of the pseudotumoural cases and in 53.2% in the classical NBD condition. Although a positive association between this allele and BD condition has been frequently described in different ethnic groups [2931] , its role in the pathogeny of BD disease remains unclear.
Pseudotumoural NBD was inaugural of the disease in one-third of patients. As a consequence, delayed diagnosis was common with increased risk of neurological sequelae. Clinical manifestations were often severe and consisted of headache and pyramidal signs. Compared with classical NBD, patients with the pseudotumoural form had a higher Rankin's score at diagnosis, more frequent motor involvement (hemi-or tetraparesis) and less frequent brainstem signs. Morphological examination showed large pseudotumoural lesions despite aspecific limited signs of pyramidal irritation without neurological deficiency, such as in our Case 3. Morphological examination consisted of MRI and/or CT scan. In most cases, lesions were seen in both testings. However, MRI seemed to be most sensitive in some cases where CT scans were normal. In contrast to classical NBD, patients with the pseudotumoural NBD mainly have one intracerebral space-occupying large lesion. The localization was often capsulo-thalamic, but may be cortical, whereas the common small lesions of classical NBD were located in the brainstem and mesodiencephalic junction (personal communication and ref. [28] ). As in classical NBD, the neurological lesions showed T2W hyperintensity and initially T1W hypointensity with contrast enhancement and peripheral oedema. These lesions were related to clinical disturbance, and improved with steroids and immunosuppressive drugs. Differential diagnoses include infectious lesions, such as bacterial abscess or tuberculoma. Other spaceoccupying lesions, such as cerebral glioblastoma or lymphoma, may be evoked. Rarely, an inflammatory condition such as sarcoidosis, Wegener's disease, multiple sclerosis (Balo's type) or granulomatous pseudotumour may be discussed. Histopathological examination should be recommended to rule out infectious or tumoural diseases, and to avoid the inadequate use of immunosuppressive agents [28, 3234] .
Frequent pathological features of classical NBD are small, scattered foci of perivascular infiltrate of CD45RO+ T lymphocytes and CD68+ monocytes. High levels of cytokines, such as IL-21, IL-17A or IL-6, are present and may contribute to the pathophysiology of NBD ( [34] and David Saadoun, personal communication). When performed, the pathological findings of pseudotumoural NBD mainly showed large perivascular inflammatory infiltrate of neutrophilic and lymphocytic type. Necrosis was reported in some cases, but necrotizing vasculitis was never seen. These aspecific features are similar to those reported in necropsic studies of classical NBD [33] .
The neurological prognosis may be assessed by the Rankin's score. The Rankin's score was higher at diagnosis of pseudotumoural NBD compared with classical NBD, confirming the more severe neurological presentation of the former. The prognosis of pseudotumoural NBD may thus be worsened because of more severe presentation, longer time to diagnosis and/or delayed treatment because of diagnostic difficulties.
Treatment of NBD includes CSs associated with DMARDs. AZA [35, 36] , MTX [37, 38] , CYC [39, 40] or anti-TNF-a [41] have been used mainly in retrospective studies. CSs may be used with initial i.v. methlyprednisolone infusions and then oral prednisone at a 1 mg/kg daily dose [42] . In pseudotumoural NBD cases, 95.5% of patients were treated with steroids, 36.4% received CYC and 18.2% AZA. When such regimens were used, clinical and morphological improvements were rapidly seen. Complete clinical and imaging remission was achieved in 60.9% patients. A similar rate of complete remission was noted in our classical NBD patients. In two patients, surgical excision of the pseudotumoural lesion was needed to avoid intracranial compression, and one patient died [19] . Another patient died from a bedridden state complication. This highlights the importance of a rapid diagnosis and a reduced time to treatment, to avoid sequelae and/or death.
We acknowledge some limitations in our study. Our analysis was performed as a retrospective review. We were unable to collect complete longitudinal data on patients who were seen only on an intermittent consultation basis. Some of our patients with pseudotumoural NBD did not fulfil the international criteria for BD [1] . As a result, patients have been selected according to O'Duffy criteria [8] and/or expert opinions.
In conclusion, pseudotumoural NBD is a rare but severe condition. In the spectrum of space-occupying lesions, when diagnosis is unclear, looking for classical manifestations of BD may be helpful. Stereotactic biopsy of the lesion may rule out infection or tumoural processes, but is aspecific. Rapid recognition of this condition reduces the delay to treatment, and thus improves functional and vital prognosis.
Rheumatology key messages
. The pseudotumoural form of NBD is a rare and life-threatening condition. . CNS imaging showed pseudotumoural lesions mainly in the capsulo-thalamic area. . Immunosuppressive therapy (CSs, CYC) can improve neurological performance, evaluated by the Rankin's score.
FIG. 3 Comparison of the proportion of patients with a
Rankin's score <3 at diagnosis and after treatment. In pseudotumoural NBD, 34.8% of patients had a Rankin's score <3 at diagnosis vs 78.3% under treatment (*P < 0.01, left column). In classical NBD, 75.3% of patients had a Rankin's score <3 at diagnosis vs 83% under treatment (NS, right column).
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